FdaApplication
ANDA 214436
Identifiers
- fda_app_no: ANDA214436
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | ANDA |
| approval_date | 2022-08-18 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PEMETREXED DISODIUM | PEMETREXED DISODIUM | EQ 100MG BASE/VIAL | POWDER;INTRAVENOUS |
| PEMETREXED DISODIUM | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER;INTRAVENOUS |
2 products